Zusammenfassung
Die PTCA stellt ein attraktives Konzept zur Behandlung der instabilen Angina pectoris und des akuten Herzinfarkts dar. Mit der PTCA kann nicht nur das Infarktgefäß wiedereröffnet, sondern auch die zugrundeliegende Stenose erweitert werden. Außerdem erhält man durch die Angiographie wichtige Informationen über den gesamten Koronarstatus, die die weitere Behandlungsstrategie (konservativ, interventionell oder operativ) bestimmen. Die Probleme der PTCA bei akuten koronaren Syndromen bestehen vor allem in Reokklusionen, vaskulären Komplikationen an den arteriellen Zugangswegen, der Zeitverzögerung bis zum Therapiebeginn und der Vorhaltung einer 24-h-Herzkatheterlaborbereitschaft.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242–250, 326:310-318
Theroux P, Ouimet H, McCans J et al. (1988) Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 319:1105–1111
The RISC Group (1990) Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 336: 827–830
The TIMI HIB Investigators (1994). Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Qwave myocardial infarction:results of the TIMI IIIB trial. Circulation 89:1545–1556
Vogt A, Bonzel T, Harmjanz D et al. (1997) PTCA Registry of the German Community Hospitals. Eur Heart J 18:1110–1114
EPIC Investigators (1994) Use of a monoclonal directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 330:956–961
Topol EJ, Califf R, Weisman HF et al. (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343:881–884
Neuhaus KL, Zeymer U (1995) Prevention and managment of thrombotic complications during coronary interventions. Eur Heart J 16 [Suppl L]: 63–67
Michels KB, Yusuf S (1995) Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? Circulation 91:476–485
TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue-type plasminogen activator in acute myocardial infarction. Results of the TIMI phase II trial. N Engl J Med 320:818–827
Simoons ML, Arnold AER, Betriu A et al. (1988) Thrombolysis with rt-PA in acute myocardial infarction: no additional benefit of immediate PTCA. Lancet 1:197–202
Topol EJ, Califf RM, George BS et al. (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.N Engl J med 317:581–588
Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL (1993) Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 21:1391–1395
Ellis SG, van de Werf F, Ribeiro da Silva E, Topoe EJ (1992) Present status of rescue coronary angioplasty:current polarization of opinion and randomized trials. J Am Coll Cardiol 19:681–686
Abbottsmith CW, Topol EJ, George BS et al. (1990) Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 16:770–778
Ellis SG, Ribeiro da Silva E, Heyndrickx G et al. (1994) Randomized comparison of rescue angioplasty with conservative managment of patients with early failure of thrombolysis for acute myocardial infarction. Circulation 90:2280–2284
Hartzler GO, Ruherford BD, McConahay DR (1983) Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 106:965–973
Ellis SG, O’Neill WW, Bates ER, Walton JA, Nabel EG, Topol EJ (1989) Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol 13:1122–1126
Ribeiro EE, Silva LA, Carneiro R et al. (1993) Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 22:376–380
Grines CL, Browne KF, Marco J et al. (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328:673–679
Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reibers JHC, Suryaranata H (1993) A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328:680–684
Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspieger MR, Gersh BJ (1993) Immediate angioplasty compared with the adminstration of a thrombolytic agent followed by conservative therapy for myocardial infarction. N Engl J Med 328:685–691
Neuhaus KL, Vogt A, Harmjanz D, von Leitner E, Wirtzfeld A, Niederer W, Merx W, for the ALKK study Group (1996) Primary PTCA in acute myocardial infarction: results from a german multicenter registry. J Am Coll Cardiol 27 (Suppl A) :62A
Ellis S (1996) the GUSTO IIb angioplasty substudy. Presented at the American College of Cardiology Scientific Sessions, March 27,1996, Orlando, USA
Every N, Parsons LS, Hlatky M, Martin JS, Weaver WD, for the MITI Investigators (1996) A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction.N Engl J Med 335:1253–1260
Monassier JP, Elias J, Meyer P, Morice MC, Royer T, Cribier A (1996) STENTIM I: The French registry of stenting at acute myocardial infarction. J Am Coll Cardiol 27 [Suppl A]: 68A
Verna E, Castiglioni B, Onofri M, Boscarrini M, Balian V, Repetto S (1995) Intracoronary stenting of the infarct-related artery without anticoagulation in acute myocardial infarction. Eur Heart J 16(Abstr) [Suppl]: 12
Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330:1724–1730
Bates ER, Topol EJ (1992) Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 18:1077–1084
Bengtson JR, Kaplan AJ, Pieper KS et al. (1992) Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 20:1482–1489
Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S (1992) Early revascularisation improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 19:907–914
Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O’Neill WW (1991) Multicenter registry of angioplasty therapy of cardiogenic shock, initial and lond-term survival. J Am Coll Cardiol 17:599–603
Hochman JS, Boland J, Sleeper LA et al. (1995) Current spectrum of cardiogenic shock and effect of early revascularisation on mortality. Results of an international registry. Circulation 91:873–881
Ohman EM, George BS, White CJ et al. (1994) Use of aortic counterpulsation to improve sustained coronary patency during acute myocardial infarction. Results of a randomised trial. Circulation 90:792–799
Zeymer U, Reissig M, Neuhaus KL (1993) Einsatz einer perkutan anschließbaren Herz-Lungenmaschine unter Reanimationsbedingungen im kardiogenen Schock bei akutem Herzinfarkt. Dtsch Med Wochenschr 118:1755–1758
Smalling RW, Sweeney M, Lachterman B et al. (1994) Transvalvular ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. Evidence for recovery from near fatal myocardial stunning. J Am Coll Cardiol 23:637–644
Overlie PA, Shawl FA, Vogel RA, Mooney MR, Smith SC, Stertzer S (1995) Emergency cardiopulmonary support in cardiac arrrest and cardiogenic shock: enhanced survival from the registry. J Am Coll Cardiol 25:151A
Boden W, O’Rourke RA, Crawford MH et al. (1998) Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 338:1785–1792
Hamm CW, Heeschen C, Goldmann B et al. (1999) Benefit of Abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 340:1623–1629
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zeymer, U., Neuhaus, KL. (2000). PTCA während akuter koronarer Syndrome. In: Hess, O.M., Simon, R.W.R. (eds) Herzkatheter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56967-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-56967-8_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62957-0
Online ISBN: 978-3-642-56967-8
eBook Packages: Springer Book Archive